California State Teachers Retirement System Biotechnology

California State Teachers Retirement System

$78.8 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
TERN Terns Pharmaceuticals, Inc.	$143M	$14,000 0.0% of portfolio	5,171	Q2 2024 Reduced 19.34%
ABSI Absci Corp	$259M	$14,000 0.0% of portfolio	5,787	Q2 2024 New
GLUE Monte Rosa Therapeutics, Inc.	$217M	$14,000 0.0% of portfolio	3,049	Q2 2024 Reduced 27.58%
CMPX Compass Therapeutics, Inc.	$263M	$14,000 0.0% of portfolio	7,390	Q2 2024 Reduced 19.46%
ALLO Allogene Therapeutics, Inc.	$175M	$13,000 0.0% of portfolio	9,409	Q1 2025 Reduced 93.06%
FULC Fulcrum Therapeutics, Inc.	$379M	$12,000 0.0% of portfolio	4,496	Q2 2024 New
VYGR Voyager Therapeutics, Inc.	$114M	$11,000 0.0% of portfolio	3,333	Q2 2024 Reduced 15.77%
YMAB Y M Abs Therapeutics, Inc.	$206M	$11,000 0.0% of portfolio	2,665	Q1 2025 Reduced 90.96%
ITOS I Teos Therapeutics, Inc.	$360M	$11,000 0.0% of portfolio	1,967	Q2 2024 Added 1,070.77%
FDMT 4 D Molecular Therapeutics, Inc.	$128M	$11,000 0.0% of portfolio	3,677	Q1 2025 Reduced 85.89%
OLMA Olema Pharmaceuticals, Inc.	$185M	$11,000 0.0% of portfolio	3,064	Q1 2025 Reduced 90.63%
XOMA Xoma Corp	$312M	$11,000 0.0% of portfolio	582	Q2 2024 Reduced 20.82%
VRCA Verrica Pharmaceuticals Inc.	$327M	$10,000 0.0% of portfolio	1,372	Q2 2024 Reduced 34.64%
FENC Fennec Pharmaceuticals Inc.	$215M	$10,000 0.0% of portfolio	1,698	Q2 2024 Reduced 6.96%
CRDF Cardiff Oncology, Inc.	$139M	$9,000 0.0% of portfolio	3,062	Q2 2024 Reduced 7.28%
CADL Candel Therapeutics, Inc.	$142M	$9,000 0.0% of portfolio	1,615	Q2 2024 Reduced 11.08%
ENTA Enanta Pharmaceuticals Inc	$148M	$8,000 0.0% of portfolio	1,456	Q2 2024 Reduced 28.52%
NKTR Nektar Therapeutics	$1.79B	$8,000 0.0% of portfolio	12,936	Q2 2024 New
PBYI Puma Biotechnology, Inc.	$154M	$8,000 0.0% of portfolio	2,999	Q2 2024 New
DSGN Design Therapeutics, Inc.	$218M	$8,000 0.0% of portfolio	2,275	Q2 2024 Reduced 30.94%
QSI Quantum Si Inc	$205M	$8,000 0.0% of portfolio	7,257	Q2 2024 Reduced 29.06%
ADCT Adc Therapeutics Sa	$208M	$8,000 0.0% of portfolio	5,994	Q2 2024 Reduced 15.37%
INMB Inmune Bio, Inc.	$115M	$8,000 0.0% of portfolio	1,078	Q2 2024 Reduced 17.9%
RGLS Regulus Therapeutics Inc.	$119M	$8,000 0.0% of portfolio	4,576	Q2 2024 New
ELYM Eliem Therapeutics, Inc.	$109M	$8,000 0.0% of portfolio	2,169	Q2 2024 Reduced 75.66%
ALEC Alector, Inc.	$114M	$7,000 0.0% of portfolio	5,848	Q1 2025 Reduced 90.97%
SCPH Sc Pharmaceuticals Inc.	$108M	$7,000 0.0% of portfolio	3,013	Q2 2024 Reduced 31.73%
NKTX Nkarta, Inc.	$85.6M	$7,000 0.0% of portfolio	3,834	Q2 2024 Added 26.12%
CCCC C4 Therapeutics, Inc.	$75.8M	$7,000 0.0% of portfolio	4,522	Q2 2024 Reduced 6.06%
PROK Prokidney Corp Ord Shs Cl A(Cy	$40.6M	$7,000 0.0% of portfolio	8,311	Q2 2024 Reduced 45.04%
CHRS Coherus Bio Sciences, Inc.	$56.7M	$6,000 0.0% of portfolio	7,976	Q2 2024 Reduced 24.43%
EDIT Editas Medicine, Inc.	$144M	$6,000 0.0% of portfolio	6,005	Q2 2024 Added 1,178.93%
KOD Kodiak Sciences Inc.	$189M	$6,000 0.0% of portfolio	2,364	Q2 2024 Reduced 27.51%
ZNTL Zentalis Pharmaceuticals, Inc.	$74.1M	$6,000 0.0% of portfolio	4,141	Q2 2024 Added 1,166.89%
FHTX Foghorn Therapeutics Inc.	$204M	$6,000 0.0% of portfolio	1,830	Q2 2024 Reduced 10.47%
ATOS Atossa Therapeutics, Inc.	$103M	$6,000 0.0% of portfolio	9,165	Q2 2024 New
LYEL Lyell Immunopharma, Inc.	$2.23B	$6,000 0.0% of portfolio	11,644	Q2 2024 Added 989.65%
LRMR Larimar Therapeutics, Inc.	$112M	$6,000 0.0% of portfolio	3,048	Q2 2024 Added 16.47%
FATE Fate Therapeutics Inc	$111M	$5,000 0.0% of portfolio	7,254	Q2 2024 Added 1,135.91%
MGNX Macrogenics Inc	$83.6M	$5,000 0.0% of portfolio	4,454	Q2 2024 Added 957.99%
CRBU Caribou Biosciences, Inc.	$84M	$5,000 0.0% of portfolio	5,961	Q2 2024 Reduced 27.6%
VTYX Ventyx Biosciences, Inc.	$136M	$5,000 0.0% of portfolio	4,404	Q2 2024 Reduced 6.42%
CABA Cabaletta Bio, Inc.	$51.9M	$4,000 0.0% of portfolio	3,338	Q2 2024 Added 913.33%
XBIT X Biotech Inc.	$81M	$4,000 0.0% of portfolio	1,482	Q2 2024 Reduced 9.51%
BDTX Black Diamond Therapeutics, Inc.	$90.1M	$4,000 0.0% of portfolio	2,940	Q2 2024 Reduced 8.47%
SAVA Cassava Sciences Inc	$75.8M	$4,000 0.0% of portfolio	2,943	Q1 2025 Reduced 93.03%
VERU Veru Inc.	$49.7M	$4,000 0.0% of portfolio	9,571	Q2 2024 New
BMEA Biomea Fusion, Inc.	$53M	$4,000 0.0% of portfolio	2,002	Q2 2024 Added 1,151.9%
GLSI Greenwich Life Sciences, Inc.	$116M	$4,000 0.0% of portfolio	433	Q2 2024 New
LCTX Lineage Cell Therapeutics, Inc.	$192M	$4,000 0.0% of portfolio	10,705	Q2 2024 Reduced 19.76%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.